drugset / Trial / NCT05715346
LEV102 Topical Gel in Acquired Blepharoptosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 1/2a, multicenter, randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study conducted in adult subjects with acquired blepharoptosis.
Timeline
- Start
- 2023-02-23
- Primary completion
- 2023-06-24
- Completion
- 2023-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxymetazoline | Other / unclassified | 1 % | Topical |
| Subject | Oxymetazoline | Other / unclassified | 2 % | Topical |